A subset of NSCLC cell lines is FOXA1 dependent. A, Scatterplot depicting FOXA1 gene effect, or degree of essentiality, as a function of its expression. Each dot represents a cell line. Data are curated from The Cancer Dependency Map (Broad Institute). Red text, breast cancer; blue text, prostate cancer; green text, lung cancer cell lines. B, Bar graph depicting FOXA1 gene effect in NSCLC cell lines as in A arranged in order of increasing FOXA1 expression. Positive gene effect values signify a proliferative advantage conferred by FOXA1 knockout, whereas negative gene effect values signify a proliferative disadvantage conferred by FOXA1 knockout. C, Immunoblot demonstrating knockdown of FOXA1 in Renilla and FOXA1 knockdown in NCI-H441 cells....
FoxM1 promotes the proliferation of CRC cells. (A and B) The validation of the FoxM1 overexpression ...
Contains fulltext : 200105.pdf (publisher's version ) (Open Access)Estrogen recept...
<p>(A) Representative FOXM1 immunostained section is shown from the chemosensitive patient group, (B...
FOXA1 and GR regulate the expression of targets involved in growth factor receptor activation and ce...
Growth promoting functions of GR in FOXA1/GR-dependent NSCLC can be inhibited by ORIC-101. A, Chemic...
Identification of a FOXA1–GR interaction through endogenous purification of FOXA1-associated protein...
Supplemental figure S1 data panels and legend accompanying main body figure 2. Supplementary Figure ...
Supplemental figure S2 data panels and legend accompanying main body figure 3. Supplementary figure ...
Supplemental figure S3 data panels and legend accompanying main body figure 4. Supplementary figure ...
<p>A: −1,124–11,114 bp revealed the presence of two CpG islands (positions −1,124–876 and 10,676–11,...
Background: FOXP1, a transcriptional regulator of lymphocyte development, is abnormally expressed in...
Activation of β-catenin decreases butyrophilin-like molecule expression. A and B, Correlation betwee...
<p>A. Graph showing quantification of immunocytochemistry where % Ki67 (n = 3) or % EdU (n = 6) is p...
The pioneering function of FOXA1 establishes estrogen-responsive transcriptomes in luminal breast ca...
<p>Dual immunofluorescence of radical cystectomy patient samples depicting co-localization of FOXA1 ...
FoxM1 promotes the proliferation of CRC cells. (A and B) The validation of the FoxM1 overexpression ...
Contains fulltext : 200105.pdf (publisher's version ) (Open Access)Estrogen recept...
<p>(A) Representative FOXM1 immunostained section is shown from the chemosensitive patient group, (B...
FOXA1 and GR regulate the expression of targets involved in growth factor receptor activation and ce...
Growth promoting functions of GR in FOXA1/GR-dependent NSCLC can be inhibited by ORIC-101. A, Chemic...
Identification of a FOXA1–GR interaction through endogenous purification of FOXA1-associated protein...
Supplemental figure S1 data panels and legend accompanying main body figure 2. Supplementary Figure ...
Supplemental figure S2 data panels and legend accompanying main body figure 3. Supplementary figure ...
Supplemental figure S3 data panels and legend accompanying main body figure 4. Supplementary figure ...
<p>A: −1,124–11,114 bp revealed the presence of two CpG islands (positions −1,124–876 and 10,676–11,...
Background: FOXP1, a transcriptional regulator of lymphocyte development, is abnormally expressed in...
Activation of β-catenin decreases butyrophilin-like molecule expression. A and B, Correlation betwee...
<p>A. Graph showing quantification of immunocytochemistry where % Ki67 (n = 3) or % EdU (n = 6) is p...
The pioneering function of FOXA1 establishes estrogen-responsive transcriptomes in luminal breast ca...
<p>Dual immunofluorescence of radical cystectomy patient samples depicting co-localization of FOXA1 ...
FoxM1 promotes the proliferation of CRC cells. (A and B) The validation of the FoxM1 overexpression ...
Contains fulltext : 200105.pdf (publisher's version ) (Open Access)Estrogen recept...
<p>(A) Representative FOXM1 immunostained section is shown from the chemosensitive patient group, (B...